NCT00611143View on ClinicalTrials.gov

Atorvastatin for Prevention of Postoperative Atrial Fibrillation After Off-Pump Coronary Artery Bypass Grafting Surgery

NACompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

May 31, 2007

Conditions
Coronary Artery Bypass
Interventions
DRUG

atorvastatin

atorvastatin 20 mg/d, started 3 days before surgery

Trial Locations (1)

135-710

Cardiac and Vascular Center; Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT00611143 - Atorvastatin for Prevention of Postoperative Atrial Fibrillation After Off-Pump Coronary Artery Bypass Grafting Surgery | Biotech Hunter | Biotech Hunter